Net Loss Per Share - Schedule of Antidilutive Securities (Details) - shares |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Number of potential common shares excluded (in shares) | 2,465,502 | 2,672,926 | 2,056,171 | 2,617,340 |
| Options to Purchase Common Stock [Member] | ||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Number of potential common shares excluded (in shares) | 1,537,641 | 1,504,062 | 1,571,706 | 1,438,231 |
| Restricted Stock Units [Member] | ||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Number of potential common shares excluded (in shares) | 349,889 | 0 | 193,882 | 0 |
| Warrants to Purchase Common Stock [Member] | ||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Number of potential common shares excluded (in shares) | 577,972 | 1,168,864 | 290,583 | 1,179,109 |